Antioxidant oral supplement might help in macular degeneration

NEW YORK (Reuters Health) - An antioxidant oral supplement (Ocuvite, Bausch and Lomb), in particular its lutein component, may provide benefits in patients with early age-related macular degeneration (AMD), according to new findings from a secondary analysis of a clinical trial (CARMA).

Full Story →